169 related articles for article (PubMed ID: 9744685)
1. Prevalence of Chlamydia pneumoniae specific antibodies in different clinical situations and healthy subjects in Izmir, Turkey.
Gencay M; Dereli D; Ertem E; Serter D; Puolakkainen M; Saikku P; Boydak B; Dereli S; Ozbakkaloglu B; Yorgancioglu A; Tez E
Eur J Epidemiol; 1998 Jul; 14(5):505-9. PubMed ID: 9744685
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae immunoglobulin G and A antibodies in a healthy Finnish population as analyzed by quantitative enzyme immunoassays.
Tuuminen T; Varjo S; Ingman H; Weber T; Oksi J; Viljanen M
Clin Diagn Lab Immunol; 2000 Sep; 7(5):734-8. PubMed ID: 10973446
[TBL] [Abstract][Full Text] [Related]
3. [Detection of serum Chlamydia pneumoniae antibodies and analysis of epidemiologic data in 5 years].
Cui J; Yan W; Ni A; Kong L; Chen L
Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(12):919-23. PubMed ID: 24854912
[TBL] [Abstract][Full Text] [Related]
4. Seroepidemiologic study of Chlamydia pneumoniae and other chlamydial species in a hyperendemic area for trachoma in the Sudan.
Mahmoud E; Elshibly S; Mardh PA
Am J Trop Med Hyg; 1994 Oct; 51(4):489-94. PubMed ID: 7943577
[TBL] [Abstract][Full Text] [Related]
5. Chlamydia pneumoniae IgA- and IgG antibodies in young survivors of myocardial infarction. A comparison of antibody detection by a microimmunofluorescence test and an enzyme immunoassay.
Halvorsen DS; Børvik T; Njølstad I; Gutteberg TJ; Vorland LH; Hansen JB
J Intern Med; 2002 Feb; 251(2):142-7. PubMed ID: 11905590
[TBL] [Abstract][Full Text] [Related]
6. [Investigation of Chlamydophila pneumoniae seropositivity and risk factors in patients with atherosclerotic vascular disease in Sivas, Turkey].
Kılıç ZB; Poyraz O; Kılıç AT
Mikrobiyol Bul; 2012 Jan; 46(1):156-8. PubMed ID: 22399186
[TBL] [Abstract][Full Text] [Related]
7. Possible role of chronic infection with Chlamydia pneumoniae in Japanese patients with acute myocardial infarction.
Kosaka C; Hara K; Komiyama Y; Takahashi H
Jpn Circ J; 2000 Nov; 64(11):819-24. PubMed ID: 11110424
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Chlamydia pneumoniae antibodies in Hungary.
Marton A; Károlyi A; Szalka A
Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):139-42. PubMed ID: 1396727
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of serological tests detecting Chlamydophila pneumoniae-specific immunoglobulin M antibody.
Miyashita N; Obase Y; Fukuda M; Shoji H; Mouri K; Yagi S; Yoshida K; Ouchi K; Oka M
Intern Med; 2006; 45(20):1127-31. PubMed ID: 17106155
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of Chlamydophila pneumoniae in ischaemic heart disease.
Monno R; Fumarola L; Trerotoli P; Giannelli G; Correale M; Brunetti D; Di Biase M
New Microbiol; 2010 Oct; 33(4):381-5. PubMed ID: 21213597
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease by micro-immunofluorescence and ELISA.
Verkooyen RP; Van Lent NA; Mousavi Joulandan SA; Snijder RJ; van den Bosch JM; Van Helden HP; Verbrugh HA
J Med Microbiol; 1997 Nov; 46(11):959-64. PubMed ID: 9368538
[TBL] [Abstract][Full Text] [Related]
12. A seroepidemiologic study of Chlamydia pneumoniae, Chlamydia trachomatis and Chlamydia psittaci in different populations on the mainland of China.
Ni AP; Lin GY; Yang L; He HY; Huang CW; Liu ZJ; Wang RS; Zhang JS; Yu JY; Li N; Wang JB; Yang HY
Scand J Infect Dis; 1996; 28(6):553-7. PubMed ID: 9060055
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction.
Ridker PM; Kundsin RB; Stampfer MJ; Poulin S; Hennekens CH
Circulation; 1999 Mar; 99(9):1161-4. PubMed ID: 10069783
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of Chlamydia pneumoniae antibodies in stroke in young.
Bandaru VC; Boddu DB; Laxmi V; Neeraja M; Kaul S
Can J Neurol Sci; 2009 Nov; 36(6):725-30. PubMed ID: 19960750
[TBL] [Abstract][Full Text] [Related]
15. Association of chronic infection of Chlamydia pneumoniae and coronary heart disease in the Japanese.
Miyashita N; Toyota E; Sawayama T; Matsumoto A; Mikami Y; Kawai N; Takada K; Niki Y; Matsushima T
Intern Med; 1998 Nov; 37(11):913-6. PubMed ID: 9868950
[TBL] [Abstract][Full Text] [Related]
16. Chlamydia pneumoniae serological status is not associated with asthma in children or young adults.
Mills GD; Lindeman JA; Fawcett JP; Herbison GP; Sears MR
Int J Epidemiol; 2000 Apr; 29(2):280-4. PubMed ID: 10817126
[TBL] [Abstract][Full Text] [Related]
17. The prevalence and regional distribution of antibodies against Chlamydia pneumoniae (strain TWAR) in Finland in 1958.
Karvonen M; Tuomilehto J; Naukkarinen A; Saikku P
Int J Epidemiol; 1992 Apr; 21(2):391-8. PubMed ID: 1428498
[TBL] [Abstract][Full Text] [Related]
18. [Importance of Chlamydia pneumoniae as a new respiratory pathogen].
Bartolomé C; Mata M; Bernárdez I
Microbiologia; 1996 Mar; 12(1):51-4. PubMed ID: 9019134
[TBL] [Abstract][Full Text] [Related]
19. [Chronic Chlamydia pneumonia infection in patients with chronic obstructive pulmonary disease].
Mazur E; Niedźwiadek J; Chmielewska-Badora J; Gryglicka B; Kozioł-Montewka M; Milanowski J
Pneumonol Alergol Pol; 2000; 68(5-6):261-4. PubMed ID: 11004865
[TBL] [Abstract][Full Text] [Related]
20. Importance of methodology in determination of Chlamydia pneumoniae seropositivity in healthy subjects and in patients with coronary atherosclerosis.
Hoymans VY; Bosmans JM; Van Renterghem L; Mak R; Ursi D; Wuyts F; Vrints CJ; Ieven M
J Clin Microbiol; 2003 Sep; 41(9):4049-53. PubMed ID: 12958224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
